# Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures

> **NCT03602118** · PHASE3 · WITHDRAWN · sponsor: **PharPoint Research, Inc.**

## Conditions studied

- Neonatal Seizure

## Interventions

- **DRUG:** Phenobarbital Sodium Injection

## Key facts

- **NCT ID:** NCT03602118
- **Lead sponsor:** PharPoint Research, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-11
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrawing the subject IND
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602118, "Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03602118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*